DDRI-18
DDRI-18 is a novel small molecule inhibitor that regulates the DNA damage response with sensitizing and anticancer activities, inhibits non-homologous end-joining (NHEJ) DNA repair and enhances the cytotoxicity of anticancer DNA damage compounds.
Product Specifications
CAS Number
4402-18-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
416.48
Molecular Formula
C26H20N6
Notes
Research use only, not for human use.
Receptor
DNA/RNA Synthesis
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6491738-01 0.2 mL
PAEL Receptor, CT (Probable G-protein Coupled Receptor 37, Endothelin B Receptor-like Protein-1, ETBR-LP-1, Parkin-associated Endothelin Receptor-like Receptor, PAELR, GPR37) (FITC)
Sign In for Pricing
View Details 
MBS6491738-02 5x 0.2 mL
PAEL Receptor, CT (Probable G-protein Coupled Receptor 37, Endothelin B Receptor-like Protein-1, ETBR-LP-1, Parkin-associated Endothelin Receptor-like Receptor, PAELR, GPR37) (FITC)
Sign In for Pricing
View Details 
MBS8120914-02 5x 0.1 mg
USP7 Protein, Human, Recombinant (aa 208-560)
Sign In for Pricing
View Details